HSPH1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.88304927206673E-12
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.365000E-03
Normal-vs-Stage2
1.595600318538E-10
Normal-vs-Stage3
6.565400E-01
Normal-vs-Stage4
1.073840E-01
Stage1-vs-Stage2
9.037400E-01
Stage1-vs-Stage3
2.573500E-02
Stage1-vs-Stage4
3.118600E-01
Stage2-vs-Stage3
1.647810E-02
Stage2-vs-Stage4
1.601790E-01
Stage3-vs-Stage4
1.251180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.3162028678646E-11
Normal-vs-AfricanAmerican
6.381700E-02
Normal-vs-Asian
2.202000E-02
Caucasian-vs-AfricanAmerican
6.975400E-01
Caucasian-vs-Asian
9.552200E-01
AfricanAmerican-vs-Asian
5.863400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.19969999887471E-08
Normal-vs-Female
1.24310006732742E-10
Male-vs-Female
1.355770E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.340300E-02
Normal-vs-Age(41-60Yrs)
9.50020000000107E-05
Normal-vs-Age(61-80Yrs)
2.49159581855452E-11
Normal-vs-Age(81-100Yrs)
3.304900E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.415600E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.892400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.816000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.256200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.239800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.437400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.236500E-03
Normal-vs-Daily Drinker
2.863800E-03
Normal-vs-Weekly Drinker
4.355300E-03
Normal-vs-Occasional Drinker
2.324100E-03
Normal-vs-Social Drinker
7.620400E-04
Non Drinker-vs-Daily Drinker
8.510200E-01
Non Drinker-vs-Weekly Drinker
2.794800E-01
Non Drinker-vs-Occasional Drinker
7.480200E-02
Non Drinker-vs-Social Drinker
8.160400E-01
Daily Drinker-vs-Weekly Drinker
3.632600E-01
Daily Drinker-vs-Occasional Drinker
9.740500E-02
Daily Drinker-vs-Social Drinker
9.589000E-01
Weekly Drinker-vs-Occasional Drinker
3.809800E-01
Weekly Drinker-vs-Social Drinker
3.643000E-01
Occasional Drinker-vs-Social Drinker
9.383600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.617200E-01
Normal-vs-Grade 2
4.321000E-01
Normal-vs-Grade 3
1.041250E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.577700E-02
Grade 1-vs-Grade 3
3.266200E-01
Grade 1-vs-Grade 4
2.617200E-01
Grade 2-vs-Grade 3
1.073190E-01
Grade 2-vs-Grade 4
4.321000E-01
Grade 3-vs-Grade 4
1.041250E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.762380E-04
Normal-vs-NonDiabetic
2.13750000033208E-07
Diabetic-vs-NonDiabetic
7.531800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.435600E-03
Normal-vs-NoPancreatitis
2.90799999635993E-08
Pancreatitis-vs-NoPancreatitis
3.733800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.08510000043738E-07
Normal-vs-N1
7.96749999310009E-09
N0-vs-N1
4.084800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.198700E-03
Normal-vs-TP53-NonMutant
3.577600E-01
TP53-Mutant-vs-TP53-NonMutant
2.748100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
